Associated Papers
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer.
Pillai R et al.
Science Advances, 2024
38536921 (PubMed )
Supplement: sciadv.adm9859_sm.pdf
Select a paper to view details